RS190712692 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| C-reactive protein levels | G | β: 0.091 | 7E-86 | PubMed |
| Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632) | A | OR: 0.1 | 4E-25 | PubMed |
| Alzheimer's disease or family history of Alzheimer's disease | A | — | 1E-22 | PubMed |
| Albumin levels | A | β: 0.04 | 1E-21 | PubMed |
| CXCL13 protein levels | A | OR: 0.12 | 5E-20 | PubMed |
| Multi-trait sex score | — | — | 6E-20 | PubMed |
| Sphingomyelin (d18:1/24:1, d18:2/24:0) levels | A | OR: 0.25 | 3E-14 | PubMed |
| CXCL10 protein levels | A | β: 0.093 | 1E-13 | PubMed |
| XCL1 protein levels | A | β: 0.075 | 1E-12 | PubMed |
| Memory decline | — | β: 0.015 | 5E-12 | PubMed |
| Sex hormone-binding globulin levels adjusted for BMI | A | β: 0.017 | 9E-12 | PubMed |
| SOST protein levels | A | β: 0.071 | 1E-11 | PubMed |
| Memory decline in impaired cognition | — | β: 0.041 | 3E-11 | PubMed |
| Coronary artery disease | — | OR: 0.19 | 4E-11 | PubMed |
| Pulmonary heart disease (PheCode 415) | G | OR: 0.12 | 4E-11 | PubMed |
| Memory decline | — | β: 0.016 | 2E-10 | PubMed |
| Baseline memory in impaired cognition | — | OR: 0.27 | 8E-10 | PubMed |
| Baseline memory in impaired cognition | — | OR: 0.35 | 2E-9 | PubMed |
| Body fat percentage (adjusted for testosterone and SHBG) | — | OR: 0.24 | 1E-8 | PubMed |
| Baseline memory | — | OR: 0.11 | 3E-8 | PubMed |